Table 3.
Descriptive analysis of the proportion of patients to comply with treatment guidelines from 0 months to 13 years of age.
| Age (years: y, m: months) | Proportion of patients mean Phe > 6 mg/dL (> 360 μmol/L) | Proportion of patients with > 25% of samples with Phe 6 > mg/dL (> 360 μmol/L) | Proportion of patients with an insufficient number of yearly blood samples |
|---|---|---|---|
| 0–11 m (n = 73) | 7% | 14% | 2% |
| 12–23 m (n = 72) | 13% | 28% | 7% |
| 24–35 m (n = 73) | 26% | 43% | 19% |
| 36–48 m (n = 70) | 26% | 49% | 26% |
| 4 y–5 y 11 m (n = 67) | 34% | 52% | 42% |
| 6 y–7 y 11 m (n = 61) | 46% | 66% | 56% |
| 8 y–9 y 11 m (n = 42) | 55% | 64% | 60% |
| 10 y–11 y 11 m (n = 25) | 60% | 76% | 60% |
| 12 y–13 y 11 m (n = 6) | 67% | 100% | 83% |